Alzamend Neuro Inc (ALZN) USD0.0001

Sell:$0.99Buy:$1.00Price decreased$0.02 (1.97%)

Prices delayed by at least 15 minutes
Sell:$0.99
Buy:$1.00
Change:Price decreased$0.02 (1.97%)
Prices delayed by at least 15 minutes
Sell:$0.99
Buy:$1.00
Change:Price decreased$0.02 (1.97%)
Prices delayed by at least 15 minutes

Key metrics

Open$1.01
Previous close$1.02
Market cap$3.88m
P/E ratio-99999.99
Volume96,008
Dividend yield0.00%
EMS-

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue3.80m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.